Skip to main content
logo
Chordia Therapeutics Inc. (TYO:190A)
Japan flag Japan · Delayed Price · Currency is JPY
72.00
-2.00 (-2.70%)
Aug 27, 2026, 3:30 PM JST

Chordia Therapeutics Balance Sheet

Millions JPY. Fiscal year is Sep - Aug.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
May '26 Aug '25 Aug '24 Aug '23
Cash & Equivalents
2,5072,5494,3304,799
Cash & Short-Term Investments
2,5072,5494,3304,799
Cash Growth
-11.17%-41.13%-9.78%-
Prepaid Expenses
21.7724.938.1652.06
Other Current Assets
45.1595.18237.6440.52
Total Current Assets
2,5732,6694,6054,892
Property, Plant & Equipment
--2.754.43
Other Intangible Assets
--0.622.5
Other Long-Term Assets
12.2912.3223.5910.59
Total Assets
2,5862,6814,6324,909

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
May '26 Aug '25 Aug '24 Aug '23
Accounts Payable
194.92120.01382.43248.43
Accrued Expenses
0.3629.332.325.6
Current Income Taxes Payable
1.4390.554.292.42
Other Current Liabilities
56.064.532.06131.79
Total Current Liabilities
252.76244.34471.07408.24
Other Long-Term Liabilities
000-
Total Liabilities
252.77244.34471.07408.24

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
May '26 Aug '25 Aug '24 Aug '23
Common Stock
1,346876.27845.2790
Additional Paid-In Capital
2,0289,0669,0358,280
Retained Earnings
-1,048-7,508-5,722-3,895
Comprehensive Income & Other
7.122.522.9425.93
Shareholders' Equity
2,3332,4374,1614,501
Total Liabilities & Equity
2,5862,6814,6324,909

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
May '26 Aug '25 Aug '24 Aug '23
Net Cash (Debt)
2,5072,5494,3304,799
Net Cash Growth
-11.17%-41.13%-9.78%-
Net Cash Per Share
34.9937.1573.7285.02
Filing Date Shares Outstanding
77.2668.9967.6856.44
Total Common Shares Outstanding
77.2668.9967.6856.44
Working Capital
2,3212,4254,1344,483
Book Value Per Share
30.2035.3261.4979.74
Tangible Book Value
2,3332,4374,1614,498
Tangible Book Value Per Share
30.2035.3261.4879.70
Machinery
10.4810.4811.2110.68